Neotame

Neotame (CAS No.: 165450-17-9) is a synthetic aspartame derived dipeptide methyl ester and high potency non nutritive sweetener that is primarily categorized in biomedical research as a xenobiotic food related small molecule for toxicology, gut biology, and microbiome perturbation studies rather than as a pharmacological therapeutic agent, with current evidence indicating that its biological effects are best interpreted through concentration dependent cellular stress responses in intestinal systems including reduced viability and apoptosis in Caco 2 intestinal epithelial cells at elevated exposure levels and ecological shifts in gut microbial communities characterized by decreased alpha diversity and altered beta diversity in experimental settings; because validated receptor level target mapping and canonical drug like pathway annotation remain limited for this compound, mechanistic investigations generally focus on apoptosis associated signaling, epithelial barrier relevant stress biology, and host microbe interaction frameworks, while reported activity readouts are most appropriately summarized qualitatively as occurring from low to moderate micromolar and higher concentration regimes depending on assay architecture rather than as universally transferable potency constants, and typical use cases include in vitro intestinal epithelial cell models, ex vivo microbiome compatible platforms, and animal studies designed to profile metabolic and gastrointestinal system level responses, where the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives and should be selected with matrix controls, exposure duration control, and endpoint specific validation to support reproducible research grade interpretation.